Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Constance Scharff, PhD
Constance Scharff has a PhD in transformative studies from the California Institute of Integral Studies. The focus of her research is on the spiritual and transformative experiences of alcoholics and addicts. She can be reached at cscharff@sbcglobal.net.